{
    "applicationNumber": "BR 11 2022 000416-8",
    "filingDate": "11/07/2019",
    "grantDate": null,
    "title": "ANTICORPO BIESPEC\u00cdFICO, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA, CONJUGADO, POLINUCLEOT\u00cdDEO, C\u00c9LULA E USOS DO ANTICORPO BIESPEC\u00cdFICO",
    "nationalPhaseDate": [
        "10/01/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT CN2019/095603",
        "pctDate": "11/07/2019",
        "wipoNumber": null,
        "wipoDate": null
    },
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2663"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2669"
        }
    ],
    "inventors": [
        "JING ZHANG",
        "LIJUAN FANG",
        "YONGXIANG YAN",
        "LIANG ZENG",
        "PENGFEI ZHOU"
    ],
    "holders": [
        307330
    ],
    "ipcCodes": [
        "G01N 33/00",
        "A61P 35/00",
        "A61K 39/395",
        "C12N 15/09",
        "C07K 16/46"
    ]
}